Primary Care Clinics in Pendleton, IN Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Pendleton Medical Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1251 Huntzinger Blvd, Suite 100, Pendleton, IN 46064 Phone: 765-298-4567 Fax: 765-298-4567 |
Medical Practice Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 8391 S Shady Trail Dr, Pendleton, IN 46064 Phone: 317-507-2395 |
Pendleton Family Practice Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75 Village Dr, Pendleton, IN 46064 Phone: 765-778-0913 Fax: 765-778-1374 |
Dennis L. Fast Md Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Jh Walker Dr, Suite 110, Pendleton, IN 46064 Phone: 765-622-0003 Fax: 765-778-7535 |
Pharmobile Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 8975 S 800 W, Pendleton, IN 46064 Phone: 317-485-3117 Fax: 888-322-9457 |
News Archive
Stool transplant found safe and effective in children with C. difficile infections
Fecal microbiota transplant, or the transfer of stool from a healthy donor to a patient, has been found highly effective in reversing severe Clostridiodes difficile diarrheal infections in adults.
Multiple cell and gene therapies can enhance cardiac function in mice modeled with MI
Researchers at the University of Utah compared the therapeutic potential of umbilical cord-derived sub-epithelial cells (UC-SECs), bone marrow-derived mesenchymal stem cells (BM-MSCs) and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) - all derived from human tissue - along with genes (S100a1 and SDF-1a) and growth factor (VEGF165) to evaluate how injected biologics might enhance cardiac function in mice modeled with myocardial infarction (MI; commonly referred to as heart attack).
Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.
Public awareness of nanotech stuck at low level
National survey findings released indicate that Americans' awareness of nanotechnology remains low.
Improving cancer therapy achieved through taste, odor intervention
Cancer and its therapies, including chemotherapy and radiotherapy, may directly alter and damage taste and odor perception, possibly leading to patient malnutrition, and in severe cases, significant morbidity, according to a Virginia Tech - Wake Forest University Comprehensive Cancer Center compilation of various existing studies.
› Verified 8 days ago